ArticleFrontiers in endocrinology2026

BRAF and MEK inhibition beyond dabrafenib-trametinib in advanced thyroid cancer: a real-world case series.

Tzahi Yamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.